ARKADIY SHUSTERMAN: Open Payments
NPI 1316992928 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 22 payments from 6 companies in 2025. Trend: 2023 $224 · 2024 $343 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $213 |
| Novo Nordisk Inc | 3 | $73 |
| Aimmune Therapeutics, Inc. | 2 | $64 |
| PFIZER INC. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $19 |
Products named: LINZESS, Ozempic, ZENPEP, NURTEC ODT, GEMTESA, OTEZLA, CREON.
Industry payments across NY — which companies pay providers there.
